Form 4: Jeffrey Immelt Reports Changes in Beneficial Ownership of NeueHealth, Inc. Stock

Director Jeffrey Immelt reports the acquisition and disposal of NeueHealth, Inc. common stock and restricted stock units.

Summary

• On May 12, 2024, Jeffrey Immelt disposed of 4,755 shares of NeueHealth, Inc. common stock.
• The disposal was related to the vesting of 4,755 restricted stock units on the same day.
• Following the transaction, Immelt beneficially owns 13,419 shares of common stock.
• On May 13, 2024, Immelt acquired 10,500 restricted stock units, which will vest on May 13, 2025.
• After the acquisition, Immelt holds 10,500 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the document primarily reports routine transactions related to executive compensation. The acquisition of restricted stock units is a slightly positive signal.

Positives

• The acquisition of 10,500 restricted stock units indicates continued alignment with the company's future performance.

Future Outlook

The report indicates future vesting of restricted stock units, aligning director compensation with company performance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units to incentivize long-term performance, a common practice among publicly traded companies like UnitedHealth Group, CVS Health, and Humana.
• The vesting schedules, typically one year from the grant date, are standard in the industry to retain key personnel and align their interests with shareholder value.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely minimal.

Key Dates